LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/Patent Fight: Extremity Medical vs Fusion Orthopedics
Legal & Regulatory and Reimbursement

Patent Fight: Extremity Medical vs Fusion Orthopedics

May 16, 2022 2 min read Premium comments

Advertisement

#fusionorthopedicsSecondary#extremitymedical

Parsippany, New Jersey-based Extremity Medical, LLC, an orthopedic device company, has filed a patent infringement lawsuit against Mesa, Arizona-based Fusion Orthopedics, LLC, an extremity surgical solutions company.

Founded in 2008, Extremity Medical “develops next-generation products for fusion, fixation and motion-preserving systems for the upper and lower extremities of the human body, including the hands and feet.”

Extremity Medical alleges that from 2011 to 2019, Nathan Peterson worked at Extremity Medical as a sales representative. It claims that while Peterson was still employed at Extremity Medical, Peterson founded Fusion Orthopedics in 2014. Peterson is still president of Fusion Orthopedics. It further asserts that because of Peterson’s employment with Extremity Medical, Peterson gained detailed information from Extremity Medical about its products, including its IOFiX line of products.

The patent at issue is U.S. Patent No. 11,298,166, entitled “Fixation System, an Intramedullary Fixation Assembly and Method Of Use.” Extremity Medical is claiming that since its founding, Fusion Orthopedics has modeled its own products after Extremity Medical’s products. Most recently, it asserts that Fusion Orthopedics has released a product that includes elements of its IOFiX products.

In a press release, Extremity Medical CEO, Founder, and Chairman of the Board Matthew Lyons commented, “After comparing our patent to Fusion’s intraosseous platform, Extremity Medical decided to file suit to defend itself against what it believes to be infringement of a patent covering one of its most innovative products.”

Lyons continued, “It is undisputable that Mr. Peterson had intimate knowledge of Extremity Medical’s products, which he gained while representing Extremity Medical, and that he also had physical access to the Extremity Medical’s unique and patented devices, before starting Fusion Orthopedics.”

In a separate press release, Fusion Orthopedics stated, “As a matter of good public policy, Fusion Orthopedics is deeply committed to combating any such legal tactics by EM [Extremity Medical] and others. It is Fusion’s practice to recognize and respect the intellectual property of others. Fusion is undeterred in their pursuit as an innovator in technology related to foot and ankle orthopedic devices. Fusion stands by its IntraLock Fixation System, especially when wrongfully accused of patent infringement.”

Extremity Medical is asking the court to find Fusion Orthopedics guilty of patent infringement, for an injunction, for damages, and for a jury trial. As of the date of this article, Fusion Orthopedics has not yet filed a response.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy